Scientific Poster Session II -- Student, Resident, Fellow Research in Progress

Thursday, May 19, 2016: 7:00 PM-9:00 PM
90
Evaluating Vitamin D levels and the tolerability of every-other-day statin administration in patients with previous statin intolerance
Dr. Marcus Costner, PharmD, BCPS and Dr. Melissa Waterhouse, Pharm.D.
Pharmacy (119), Veterans Health Care System of the Ozarks, Fayetteville, AR
95
Evaluation of the impact of pharmacist-run tobacco cessation classes on abstinence rates in patients of a Patient-Centered Medical Home (PCMH) practice
Angela Raymond, Student (PY3)1, Lauren Wolfe, PharmD1, Jamie McConaha, PharmD, CGP, BCACP1 and Gibbs Kanyongo, Ph.D., M.A., B.S.2
1Duquesne University Mylan School of Pharmacy, Pittsburgh, PA
2School of Education, Duquesne University, Pittsburgh, PA
98
Electronic Cigarettes: The Perceptions of Pharmacists and Physicians
Alana Grabigel, PharmD Candidate 2016, Dominick DiLucente, PharmD Candidate 2017, Lauren Wolfe, PharmD and Jamie McConaha, PharmD, CGP, BCACP
Duquesne University Mylan School of Pharmacy, Pittsburgh, PA
99
Pharmacist-physician collaborative care model vs. standard care: Assessing time to blood pressure goal
Eric Parod, PharmD1, Dave Dixon, PharmD, BCPS, CDE, CLS, AACC, FNLA2, Evan Sisson, Pharm.D., M.H.A.3, Pramit Nadpara, PhD4, Dr. Leticia R. Moczygemba, PharmD, PhD5, Dan Carl, MD6 and Alan Dow, MD6
1School of Pharmacy, Virginia Commonwealth University, Richmond, VA
2Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA
3Department of Pharmacotherapy and Outcome Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA
4Virginia Commonwealth University School of Pharmacy, Richmond, VA
5Department of Pharmacotherapy and Outcomes Sciences, Virginia Commonwealth University School of Pharmacy, Richmond, VA
6VCU Health System, Richmond, VA
100
A pharmacist's impact on secondary stroke prevention
Ms. Olivia Stanton-Ameisen, PharmD Candidate 2017, BA in Medical Anthropology1, Sara Walton, PharmD Candidate 20171, Dr. Charles Ruchalski, PharmD2 and Dr. Jennifer Andres, PharmD2
1Temple University School of Pharmacy, Philadelphia, PA
2Department of Pharmacy Practice, Temple University School of Pharmacy, Philadelphia, PA
105
Barriers to medication counseling in a rural community telepharmacy setting
Dr. Grace Unruh, PharmD1, Rex Force, Pharm.D., BCPS, FCCP2 and John T. Holmes, Pharm.D., BCPS3
1School of Pharmacy, Idaho State University, Pocatello, ID
2Department of Family Medicine, Departments of Family Medicine and Pharmacy Practice, Idaho State University, Pocatello, ID
3Departments of Family Medicine and Pharmacy Practice, Idaho State University, Pocatello, ID
107
Improving adherence to a severe alcohol withdrawal protocol through targeted order-set interventions
Jessica Neal, Pharm.D.1, Jennifer Catlin, PharmD, BCPS2 and Christina Stafford, PharmD, BCPS2
1Department of Pharmacy, CoxHealth, Springfield, MO
2CoxHealth, Springfield, MO
109
Prescribing patterns of dexmedetomidine in the intensive care unit and impact on supplemental pain and sedation medications
Dr. Eunah Cheon, PharmD1 and Dr. Emily Dornblaser, PharmD, MS2
1Pharmacy Department, New York Methodist Hospital, Brooklyn, NY
2Pharmacy Practice Department, University of New England, Portland, ME
111
Pharmacist participation on adult code blue teams: a quality improvement initiative
Jennifer Empfield, PharmD, Dr. Lindsay Arnold, PharmD and Kelly Killius, Pharm.D., BCPS
Department of Pharmacy, Boston Medical Center, Boston, MA
112
Baseline experience and level of comfort with research design and implementation of current PGY1 residents in Arkansas
Mrs. Janna Hawthorne, Pharm.D.
Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock, AR
113
Risk factors for adverse events during hypertension management in the emergency department: a comparison of intravenous antihypertensive therapies
Alyssa Fixl, PharmD, Matthew Hinton, PharmD, BCPS and Kerry Mohrien, PharmD, BCPS
Temple University Hospital, Philadelphia, PA
114
Effects of a medication history process refinement using pharmacy technicians in the emergency department
Dr. Kirbie St. James, PharmD1, Dr. Candy Smith, PharmD2 and Dr. Shane Chordas, PharmD, BCPS3
1Pharmacy Practice PGY1, Sacred Heart Health System, Pensacola, FL
2Pharmacy Department, Sacred Heart Health System, Pensacola, FL
3Pharmacy Department, Sacred Heart Health System, Pensacola, FL
115
Evaluation of a pharmacist managed diabetes clinic
Nadia Aneese, PharmD1, Alexandra Halalau, MD, FACP2, Colleen Lauster, PharmD, BCPS, CDE1, Sarah Muench, PharmD, CDE1 and Janna Fett, PharmD, BCACP1
1Department of Pharmaceutical Services, Beaumont Hospital-Royal Oak, Royal Oak, MI
2Department of Internal Medicine, Beaumont Hospital-Royal Oak, Royal Oak, MI
117
Identifying missed opportunities for the pneumococcal conjugate vaccine (PCV13) in outpatient Veterans 65 years and older
Lauren Jindracek, Pharm.D.1, Jennifer Stark, Pharm.D., BCPS1 and Jean Nelson, R.N.2
1Department of Pharmacy, Veterans Health Care System of the Ozarks, Fayetteville, AR
2Department of Nursing, Veterans Health Care System of the Ozarks, Fayetteville, AR
118
Evaluating the effects of a pharmacist-led intervention program on blood pressure control within an employer sponsored healthcare clinic
Dr. Chelsea Hudak, PharmD1, Dr. Laurel Aaberg, PharmD1, Dr. Ronni Nemeth, PharmD1 and Dr. Kyle Hinkley, PharmD2
1Pharmacy Department, Confluence Health, Wenatchee, WA
2Stemilt Clinic Pharmacy, Confluence Health, Wenatchee, WA
121
Prevalence of pharmacy-led warfarin patient education in a community hospital: a retrospective review
Dr. Ashley Evans, Pharm.D., Dr. Brian Grace, Pharm.D., Dr. James Houpt, Pharm.D., BCPS and Dr. Elizabeth Englin, Pharm.D., BCPS
Pharmacy Department, CoxHealth, Springfield, MO
124
Association between procalcitonin levels and clostridium difficile infection
Dr. Kelly Ishizuka, Doctorate of Pharmacy
Loma Linda University, Loma Linda, CA
126
Evaluation of the microbiology lab addressing physicians regarding Clostridium Difficile testing
Dr. Katlin Pritchett, PharmD and Dr. Shane Chordas, PharmD, BCPS
Pharmacy Department, Sacred Heart Hospital, Pensacola, FL
127
Follow-up of emergency department microbiological cultures in the event of organism-antibiotic mismatch
Andrew Norman, PharmD
Department of Pharmacy, Cone Health - Alamance Regional Medical Center, Burlington, NC
130
Pattern of Antibiotic Therapy and Effectiveness in Gastrointestinal surgeries
Mr. Santosh Chandrashekar, Doctor of Pharmacy1, Mr. Ibel C Fredy, Doctor of Pharmacy1 and Mr. Srinivasan Ranganathan, M.Pharm.(PhD)2
1College of Pharmacy, PES College of Pharmacy, Bangalore, India
2Department of pharmacy, Annamalai University, Annamalai nager, India
138
Opioid safety initiative: clinical pharmacy intervention
Dr. Eun Pyung Im, PharmD, Dr. June Griffith, PharmD, CGP, BCPP and Dr. Debora Hamilton, RPh, PharmD
US Department of Veterans Affairs, Tuscaloosa VA Medical Center, Tuscaloosa, AL
140
Outcomes from implementation of rapid identification test for detection of gram-positive and gram-negative bacteria into a pharmacist-directed antimicrobial stewardship protocol for pediatric patients
Rebecca Thompson, PharmD1, Angel Heyerly, PharmD1 and Gordon Bokhart, PharmD2
1Department of Pharmacy, Lutheran Hospital, Fort Wayne, IN
2Research Department, Lutheran Medical Group, Fort Wayne, IN
141
Assessment of current prevention and treatment strategies for pediatric opioid-associated constipation in a community hospital setting
Sarah Berger, PharmD, Glenda Adams, RPh and Deb McFatridge, RPh, BCPPS
Pharmacy Department, CoxHealth, Springfield, MO
143
Levels of Sedation Associated with Dexmedetomidine Versus Midazolam in Critically-Ill Mechanically-Ventilated Children
Jeff Moss, PharmD and Claire Fung, PharmD
Lucile Packard Children's Hospital, Palo Alto, CA
144
Estimated cost impact of clinical pharmacist interventions in a pediatric primary care clinic
Dr. Parrish Carpenter, PharmD1 and Dr. Janesha Thomas, PharmD2
1The Children's Hospital at Sacred Heart, Pensacola, FL
2Sacred Heart Hospital, Pensacola, FL
145
Comparison of antithrombin III products in patients on extracorporeal membrane oxygenation in a children's hospital: a pilot study of recombinant antithrombin III versus human antithrombin III
Nicole Hollinger, PharmD1, Omayma Kishk, PharmD1, Allison Lardieri, PharmD2, Dr. Linda Walker, MD3 and Dr. Adnan Bhutta, M.B.B.S, FAAP3
1Department of Pharmacy, University of Maryland Medical Center, Baltimore, MD
2Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD
3School of Medicine, University of Maryland, Baltimore, MD
146
Delay in transitions of care in children admitted for lead chelation therapy with succimer
Natasha Pham, Pharm.D. Candidate 2018 and Laura L. Bio, Pharm.D., BCPS
Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA
148
Implementation and evaluation of an overdose education and naloxone distribution (OEND) program
Dr. Joshua Gauthier, PharmD1 and Dr. June Griffith, PharmD, CGP, BCPP2
1Tuscaloosa VA Medical Center, Tuscaloosa, AL
2US Department of Veterans Affairs, Tuscaloosa VA Medical Center, Tuscaloosa, AL
150
Safety and efficacy of short-course linezolid for the treatment of cholangitis in liver transplant recipients
Danielle McKimmy, P41, Dr. Margaret Jorgenson, PharmD2, Jillian Fose, PharmD1 and Jeannina Smith, MD1
1University of Wisconsin Hospital and Clinics, Madison, WI
2UW Health, Madison, WI
<< Previous Session | Next Session >>